Mimedx (MDXG) Change in Cash (2011 - 2026)

Mimedx has disclosed Change in Cash across 16 years of filings, most recently posting -$6.3 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$6.3 million, down 415.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.3 million (down 7.94% YoY), and the FY2025 annual result was $61.7 million, up 175.27% from the prior year.
• Change in Cash came in at -$6.3 million for Q1 2026 at Mimedx, down from $24.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $24.0 million in Q4 2025 to a low of -$33.5 million in Q1 2024.
• The 5-year median for Change in Cash is $2.0 million (2025), against an average of $4.3 million.
• Across the five-year window, Change in Cash plunged 1316.09% in 2022 and surged 1767.82% in 2024, its largest moves.
• Mimedx's Change in Cash stood at -$7.3 million in 2022, then surged by 111.5% to $836000.0 in 2023, then soared by 1767.82% to $15.6 million in 2024, then soared by 53.94% to $24.0 million in 2025, then slumped by 126.41% to -$6.3 million in 2026.
• The last three Change in Cash figures came in at -$6.3 million (Q1 2026), $24.0 million (Q4 2025), and $23.2 million (Q3 2025), per Business Quant data.